Clinical trial Recruiting at 1 site Interventional Ages 20 to 75

Comparing open and minimally invasive posterior stabilization for thoracic and lumbar spine fractures using 3D gait and muscle recordings

Official title: 3D Gait Analysis and Electromyography After Instrumented Stabilisation of Thoracolumbar Spine Fractures - Comparison Between Open and Minimally Invasive Approach

Run by Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. · NCT07516834 · Data updated 2026-11-12

This trial will test whether open or minimally invasive posterior stabilization leads to faster or different walking and back-muscle recovery after thoracic or lumbar spine fractures.

Quick facts

Study typeInterventional
Ages20 Years to 75 Years
SexAll
Enrollment20 (estimated)
SponsorMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Academic / other
Locations1 site (Ústí nad Labem, Ústí nad Labem Region)
StatusRecruiting
StartedFebruary 20, 2022
Main results expectedJune 2026
Study endsJuly 2026
Registry record updatedApril 8, 2026
Trial IDNCT07516834 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a thoracic or lumbar spine fracture who are planned for instrumented posterior stabilization and who do not have neurological deficits from the initial injury.

Probably not a fit

Patients with neurological deficits from the primary spine trauma, those whose fractures do not require posterior stabilization, or those unable to attend the single-center follow-up testing are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, prospective randomized trial enrolled patients with thoracic or lumbar spine fractures who required instrumented posterior stabilization and randomized them to either a conventional open approach or a minimally invasive surgical approach. Patients underwent three-dimensional gait analysis and electromyography of deep back muscles at predefined postoperative time points to track temporal patterns of physiological gait recovery. The protocol excluded patients with neurological deficits resulting from the initial trauma to focus on recovery of musculoskeletal function. All procedures and follow-up testing were performed at Masarykova Nemocnice in Ústí nad Labem, Czech Republic.

Why it matters

Potential benefit: If successful, the results could guide surgeons toward the approach that speeds restoration of normal walking and back-muscle function, improving rehabilitation and patient outcomes.

How similar studies have gone: Previous work has suggested minimally invasive posterior approaches can reduce soft-tissue damage and early pain, but detailed randomized comparisons using 3D gait analysis and deep-muscle EMG are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* fracture of thoracic or lumbar spine indicated for spine stabilization

Exclusion Criteria:

* neurological deficits as a consequence of the primary spine trauma

Where it's running

  • Krajska zdravotni, a.s., Masarykova nemocnice hospital in Usti nad Labem, Ústí Nad Labem, Ustecky kraj 40001
    Ústí nad Labem, Ústí nad Labem Region, Czechia
    Recruiting

Study contacts

  • Principal investigator: Jan Soukup, M.D. — Krajska zdravotni, a.s., Masarykova nemocnice hospital in Usti nad Labem, Ústí Nad Labem, Ustecky kraj 40001
  • Study coordinator: Jan Soukup, M.D.
  • Email: Soukup07@kzcr.eu
  • Phone: +420723705376

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.